Motley Fool: Is Tilray Finally a Buy?

Canada’s top pot producers have all seen their valuations shoot higher this year — that is, except Tilray (NASDAQ:TLRY). Over the first five months of the year, Tilray’s market cap has slipped by an unsightly 25%. Worse still, the company’s…

Motley Fool: Why Marijuana Stocks Tilray, Cronos, and New Age Beverages Fell 10% to 19% in March

What happened Shares of cannabis companies Tilray (NASDAQ:TLRY), Cronos Group (NASDAQ:CRON), and New Age Beverages (NASDAQ:NBEV) dropped 19.4%, 14.8%, and 10.4%, respectively, in March, according to data from S&P Global Market Intelligence. For context, the S&P 500 rose 1.9% last month. Those stocks have…

Motley Fool: Is the Marijuana Market Opportunity Legit?

Marijuana is one of the most exciting emerging industries for investors right now, but a lot of that excitement could be misplaced. The potential to profit from marijuana stocks will depend significantly upon cooperative governments and willing consumers, and not…

Motley Fool: Why New Age Beverages Corp Stock Popped Today

What happened Shares of New Age Beverages Corp (NASDAQ:NBEV) were surging again today after three straight days of sharp declines as the company continues to ride the broader volatility in the marijuana sector. As pot stocks rose today with highflier Tilray (NASDAQ:TLRY) up…

Motley Fool: Is Now a Good Time to Buy Tilray Inc.?

Momentum is building for marijuana stocks ahead of the opening of Canada’s recreational cannabis market in October, and Tilray Inc. (NASDAQ:TLRY) is among the industry’s biggest recent winners. Tilray’s shares have almost doubled this month because of growing optimism that…